Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Pyxis Oncology (PYXS) over the last 2 years, with Q1 2025 value amounting to $12.2 million.

  • Pyxis Oncology's Gains from Investment Securities rose 7740.11% to $12.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $12.2 million, marking a year-over-year increase of 7740.11%. This contributed to the annual value of $9.7 million for FY2024, which is 208226.4% up from last year.
  • According to the latest figures from Q1 2025, Pyxis Oncology's Gains from Investment Securities is $12.2 million, which was up 7740.11% from $7.0 million recorded in Q2 2024.
  • In the past 5 years, Pyxis Oncology's Gains from Investment Securities ranged from a high of $12.2 million in Q1 2025 and a low of $6.9 million during Q1 2024